257 related articles for article (PubMed ID: 23588806)
1. DLC-1, a candidate tumor suppressor gene, inhibits the proliferation, migration and tumorigenicity of human nasopharyngeal carcinoma cells.
Feng X; Li C; Liu W; Chen H; Zhou W; Wang L; Zhu B; Yao K; Jiang X; Ren C
Int J Oncol; 2013 Jun; 42(6):1973-84. PubMed ID: 23588806
[TBL] [Abstract][Full Text] [Related]
2. DLC-1 induces mitochondrial apoptosis and epithelial mesenchymal transition arrest in nasopharyngeal carcinoma by targeting EGFR/Akt/NF-κB pathway.
Huang W; Liu J; Feng X; Chen H; Zeng L; Huang G; Liu W; Wang L; Jia W; Chen J; Ren C
Med Oncol; 2015 Apr; 32(4):115. PubMed ID: 25779535
[TBL] [Abstract][Full Text] [Related]
3. Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma.
Peng D; Ren CP; Yi HM; Zhou L; Yang XY; Li H; Yao KT
Acta Biochim Biophys Sin (Shanghai); 2006 May; 38(5):349-55. PubMed ID: 16680376
[TBL] [Abstract][Full Text] [Related]
4. Promoter hypermethylation along with LOH, but not mutation, contributes to inactivation of DLC-1 in nasopharyngeal carcinoma.
Feng X; Ren C; Zhou W; Liu W; Zeng L; Li G; Wang L; Li M; Zhu B; Yao K; Jiang X
Mol Carcinog; 2014 Nov; 53(11):858-70. PubMed ID: 23908159
[TBL] [Abstract][Full Text] [Related]
5. The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation.
Seng TJ; Low JS; Li H; Cui Y; Goh HK; Wong ML; Srivastava G; Sidransky D; Califano J; Steenbergen RD; Rha SY; Tan J; Hsieh WS; Ambinder RF; Lin X; Chan AT; Tao Q
Oncogene; 2007 Feb; 26(6):934-44. PubMed ID: 16862168
[TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor DLC-1 induces apoptosis and inhibits the growth and invasion of colon cancer cells through the Wnt/β-catenin signaling pathway.
Wang C; Wang J; Liu H; Fu Z
Oncol Rep; 2014 May; 31(5):2270-8. PubMed ID: 24604602
[TBL] [Abstract][Full Text] [Related]
7. Anti-angiogenic pathway associations of the 3p21.3 mapped BLU gene in nasopharyngeal carcinoma.
Cheng Y; Ho RL; Chan KC; Kan R; Tung E; Lung HL; Yau WL; Cheung AK; Ko JM; Zhang ZF; Luo DZ; Feng ZB; Chen S; Guan XY; Kwong D; Stanbridge EJ; Lung ML
Oncogene; 2015 Aug; 34(32):4219-28. PubMed ID: 25347745
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-93 promotes cell growth and invasion in nasopharyngeal carcinoma by targeting disabled homolog-2.
Xu YF; Mao YP; Li YQ; Ren XY; He QM; Tang XR; Sun Y; Liu N; Ma J
Cancer Lett; 2015 Jul; 363(2):146-55. PubMed ID: 25892549
[TBL] [Abstract][Full Text] [Related]
9. MiR-24 functions as a tumor suppressor in nasopharyngeal carcinoma through targeting FSCN1.
Li YQ; Lu JH; Bao XM; Wang XF; Wu JH; Hong WQ
J Exp Clin Cancer Res; 2015 Oct; 34():130. PubMed ID: 26503504
[TBL] [Abstract][Full Text] [Related]
10. RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma.
Chow LS; Lo KW; Kwong J; To KF; Tsang KS; Lam CW; Dammann R; Huang DP
Int J Cancer; 2004 May; 109(6):839-47. PubMed ID: 15027117
[TBL] [Abstract][Full Text] [Related]
11. Pin2 telomeric repeat factor 1-interacting telomerase inhibitor 1 (PinX1) inhibits nasopharyngeal cancer cell stemness: implication for cancer progression and therapeutic targeting.
Yu C; Chen F; Wang X; Cai Z; Yang M; Zhong Q; Feng J; Li J; Shen C; Wen Z
J Exp Clin Cancer Res; 2020 Feb; 39(1):31. PubMed ID: 32028978
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-144 promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma through repression of PTEN.
Zhang LY; Ho-Fun Lee V; Wong AM; Kwong DL; Zhu YH; Dong SS; Kong KL; Chen J; Tsao SW; Guan XY; Fu L
Carcinogenesis; 2013 Feb; 34(2):454-63. PubMed ID: 23125220
[TBL] [Abstract][Full Text] [Related]
13. DOC-2/DAB2 interactive protein regulates proliferation and mobility of nasopharyngeal carcinoma cells by targeting PI3K/Akt pathway.
Wang B; Gu Q; Li J
Oncol Rep; 2017 Jul; 38(1):317-324. PubMed ID: 28586035
[TBL] [Abstract][Full Text] [Related]
14. [Effects of enhancer of zeste homolog (EZH2) downregulation on the proliferation and invasion of nasopharyngeal carcinoma cell and the possible mechanisms].
LIANG BJ; LI XP; LU J; LIN SX; LIU X; LI G; ZHANG B; WANG L; LUO HN; WAN RQ; TIAN WD
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):298-304. PubMed ID: 22800347
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-378 functions as an onco-miR in nasopharyngeal carcinoma by repressing TOB2 expression.
Yu BL; Peng XH; Zhao FP; Liu X; Lu J; Wang L; Li G; Chen HH; Li XP
Int J Oncol; 2014 Apr; 44(4):1215-22. PubMed ID: 24481647
[TBL] [Abstract][Full Text] [Related]
16. Functional characterization of THY1 as a tumor suppressor gene with antiinvasive activity in nasopharyngeal carcinoma.
Lung HL; Cheung AK; Cheng Y; Kwong FM; Lo PH; Law EW; Chua D; Zabarovsky ER; Wang N; Tsao SW; Stanbridge EJ; Lung ML
Int J Cancer; 2010 Jul; 127(2):304-12. PubMed ID: 19921696
[TBL] [Abstract][Full Text] [Related]
17. The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma.
Qiu GH; Tan LK; Loh KS; Lim CY; Srivastava G; Tsai ST; Tsao SW; Tao Q
Oncogene; 2004 Jun; 23(27):4793-806. PubMed ID: 15122337
[TBL] [Abstract][Full Text] [Related]
18. TSLC1 is a tumor suppressor gene associated with metastasis in nasopharyngeal carcinoma.
Lung HL; Cheung AK; Xie D; Cheng Y; Kwong FM; Murakami Y; Guan XY; Sham JS; Chua D; Protopopov AI; Zabarovsky ER; Tsao SW; Stanbridge EJ; Lung ML
Cancer Res; 2006 Oct; 66(19):9385-92. PubMed ID: 17018592
[TBL] [Abstract][Full Text] [Related]
19. AIMP2-DX2 Promotes the Proliferation, Migration, and Invasion of Nasopharyngeal Carcinoma Cells.
Cao Q; Zhang J; Zhang T
Biomed Res Int; 2018; 2018():9253036. PubMed ID: 29854811
[TBL] [Abstract][Full Text] [Related]
20. MiR-203a-3p suppresses cell proliferation and metastasis through inhibiting LASP1 in nasopharyngeal carcinoma.
Jiang N; Jiang X; Chen Z; Song X; Wu L; Zong D; Song D; Yin L; Wang D; Chen C; Bian X; He X
J Exp Clin Cancer Res; 2017 Oct; 36(1):138. PubMed ID: 28982387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
